代谢基因网络的模块性作为肝细胞癌的预后生物标志物
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma
摘要:
代谢异常是癌症的一个新的标志。癌细胞利用有氧糖酵解和氧化磷酸化(OXPHOS)来产生能量和合成生物质。了解癌症中的代谢重编程可以帮助设计针对代谢的治疗方法,从而改善预后。我们以前曾认为,恶性肿瘤的特征通常是癌症相关基因的表达模式更加模块化。在这项工作中,我们分析了代谢基因的表达模式的模块化方面的371肝癌(HCC)样本的癌症基因组图谱(TCGA)。我们发现,较高的模块化与糖酵解表型、较晚的肿瘤分期、较高的转移潜力和癌症复发显著相关,所有这些都导致总体预后较差。在复发的患者中,我们发现在早期至中期进展期间,更大的模块化与更差的预后相关。此外,我们开发了计算个体模块性的指标,这被证明是癌症复发和患者生存的预测指标,因此可以作为预后生物标志物。我们的总体结论是,更具侵袭性的HCC肿瘤,根据宿主生存概率的降低来判断,具有更多的代谢基因的模块化表达模式。这些结果可用于识别癌症驱动基因和药物设计。
英文摘要:
Abnormal metabolism is an emerging hallmark of cancer. Cancer cells utilize both aerobic glycolysis and oxidative phosphorylation (OXPHOS) for energy production and biomass synthesis. Understanding the metabolic reprogramming in cancer can help design therapies to target metabolism and thereby to improve prognosis. We have previously argued that more malignant tumors are usually characterized by a more modular expression pattern of cancer-associated genes. In this work, we analyzed the expression patterns of metabolism genes in terms of modularity for 371 hepatocellular carcinoma (HCC) samples from the Cancer Genome Atlas (TCGA). We found that higher modularity significantly correlated with glycolytic phenotype, later tumor stages, higher metastatic potential, and cancer recurrence, all of which contributed to poorer overall prognosis. Among patients that recurred, we found the correlation of greater modularity with worse prognosis during early to mid-progression. Furthermore, we developed metrics to calculate individual modularity, which was shown to be predictive of cancer recurrence and patients' survival and therefore may serve as a prognostic biomarker. Our overall conclusion is that more aggressive HCC tumors, as judged by decreased host survival probability, had more modular expression patterns of metabolic genes. These results may be used to identify cancer driver genes and for drug design.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。